Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Sinclair

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Aging Clinical and Experimental Research|June 20, 2022
Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotypeAlan J Sinclair, Daniel Pennells, Ahmed H Abdelhafiz
Geriatrics & Gerontology International|June 21, 2021
Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitusAhmed H Abdelhafiz, Demelza Emmerton, Alan J Sinclair
International Journal of Clinical Practice|February 25, 2021
Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomesAhmed H Abdelhafiz, Demelza Emmerton, Alan J Sinclair
Expert Review of Endocrinology & Metabolism|February 25, 2022
A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitusAhmed H Abdelhafiz, Daniel Pennells, Alan J Sinclair
The Lancet. Diabetes & Endocrinology|April 21, 2018
Mean HbA<sub>1c</sub>, HbA<sub>1c</sub> variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort studyAngus Forbes, Trevor Murrells, Henrietta Mulnier, et al.
Mechanisms of Ageing and Development|March 14, 2003
Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderlyDavid A Rider, Alan J Sinclair, Stephen P Young
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2022
Overtreatment of older people with type 2 diabetes-a high impact frequent occurrence in need of a new definitionAntoine Christiaens, Séverine Henrard, Benoit Boland, et al.
Diabetes Care|November 21, 2007
Impact of diabetes on physical function in older peopleAlan J Sinclair, Simon P Conroy, Antony J Bayer
Journal of the American Medical Directors Association|November 27, 2016
The Third Transition: The Clinical Evolution Oriented to the Contemporary Older PatientLeocadio Rodriguez-Mañas, Fernando Rodríguez-Artalejo, Alan J Sinclair
Journal of Diabetes and Its Complications|July 4, 2017
Frailty and sarcopenia - newly emerging and high impact complications of diabetesAlan J Sinclair, Ahmed H Abdelhafiz, Leocadio Rodríguez-Mañas
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Aging Clinical and Experimental Research|June 20, 2022
Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotypeAlan J Sinclair, Daniel Pennells, Ahmed H Abdelhafiz
Geriatrics & Gerontology International|June 21, 2021
Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitusAhmed H Abdelhafiz, Demelza Emmerton, Alan J Sinclair
International Journal of Clinical Practice|February 25, 2021
Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomesAhmed H Abdelhafiz, Demelza Emmerton, Alan J Sinclair
Expert Review of Endocrinology & Metabolism|February 25, 2022
A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitusAhmed H Abdelhafiz, Daniel Pennells, Alan J Sinclair
The Lancet. Diabetes & Endocrinology|April 21, 2018
Mean HbA<sub>1c</sub>, HbA<sub>1c</sub> variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort studyAngus Forbes, Trevor Murrells, Henrietta Mulnier, et al.
Mechanisms of Ageing and Development|March 14, 2003
Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderlyDavid A Rider, Alan J Sinclair, Stephen P Young
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2022
Overtreatment of older people with type 2 diabetes-a high impact frequent occurrence in need of a new definitionAntoine Christiaens, Séverine Henrard, Benoit Boland, et al.
Diabetes Care|November 21, 2007
Impact of diabetes on physical function in older peopleAlan J Sinclair, Simon P Conroy, Antony J Bayer
Journal of the American Medical Directors Association|November 27, 2016
The Third Transition: The Clinical Evolution Oriented to the Contemporary Older PatientLeocadio Rodriguez-Mañas, Fernando Rodríguez-Artalejo, Alan J Sinclair
Journal of Diabetes and Its Complications|July 4, 2017
Frailty and sarcopenia - newly emerging and high impact complications of diabetesAlan J Sinclair, Ahmed H Abdelhafiz, Leocadio Rodríguez-Mañas
Pageof 9